Table 3.
Group | Time | β | SE | LSM | SE | 95% CI | |
---|---|---|---|---|---|---|---|
Cognitive/Affective | 1 | 1.47 | 0.05 | 4.35 | 0.20 | 3.99 | 4.74 |
2 | 1.60 | 0.05 | 4.95 | 0.24 | 4.50 | 5.44 | |
3 | 1.66 | 0.06 | 5.24 | 0.28 | 4.72 | 5.82 | |
4 | 1.80 | 0.07 | 6.03 | 0.38 | 5.34 | 6.81 | |
Multiple morbidity | 1 | 1.43 | 0.03 | 4.18 | 0.11 | 3.98 | 4.40 |
2 | 1.56 | 0.03 | 4.75 | 0.13 | 4.50 | 5.01 | |
3 | 1.59 | 0.03 | 4.89 | 0.15 | 4.62 | 5.19 | |
4 | 1.65 | 0.04 | 5.19 | 0.18 | 4.87 | 5.54 | |
Osteoporosis | 1 | 1.45 | 0.04 | 4.24 | 0.14 | 3.99 | 4.51 |
2 | 1.59 | 0.04 | 4.89 | 0.17 | 4.58 | 5.22 | |
3 | 1.60 | 0.04 | 4.93 | 0.19 | 4.57 | 5.30 | |
4 | 1.68 | 0.05 | 5.34 | 0.23 | 4.92 | 5.80 | |
Vascular | 1 | 1.43 | 0.04 | 4.18 | 0.14 | 3.93 | 4.44 |
2 | 1.61 | 0.04 | 4.98 | 0.18 | 4.65 | 5.33 | |
3 | 1.58 | 0.04 | 4.85 | 0.19 | 4.49 | 5.23 | |
4 | 1.73 | 0.05 | 5.60 | 0.24 | 5.15 | 6.09 | |
Cancer | 1 | 1.40 | 0.04 | 4.04 | 0.13 | 3.81 | 4.30 |
2 | 1.55 | 0.04 | 4.68 | 0.16 | 4.39 | 4.98 | |
3 | 1.62 | 0.04 | 5.05 | 0.20 | 4.69 | 5.44 | |
4 | 1.66 | 0.05 | 5.25 | 0.22 | 4.84 | 5.68 | |
Minimal disease | 1 | 1.41 | 0.02 | 4.08 | 0.08 | 3.93 | 4.24 |
2 | 1.55 | 0.03 | 4.69 | 0.10 | 4.50 | 4.89 | |
3 | 1.57 | 0.03 | 4.79 | 0.12 | 4.57 | 5.02 | |
4 | 1.39 | 0.03 | 4.00 | 0.10 | 3.81 | 4.19 | |
Results for type III test of fixed effects | |||||||
Group | Time | Group x time interaction | |||||
F = 6.82, p < .001* | F = 156.86, p < .001* | F = 16.89, p < .001* |
Note. FM = functional mobility, LSM = least squares mean.